Avoid common mistakes on your manuscript.
Correction to: Diabetologia
The following sentence in the Discussion was inappropriately changed to a definite statement during editing: ‘Considering the mechanism of action of PB-119, which is similar to exenatide QW, PB-119 also showed superior efficacy compared with available OADs.’
The journal would like to revert back to the authors’ original phrasing as follows:
‘Considering the mechanism of action of PB-119, which is similar to exenatide QW, PB-119 could also reveal superior efficacy in comparison with available OADs.’
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s00125-021-05392-9
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ji, L., Du, Y., Xu, M. et al. Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study. Diabetologia 64, 1900–1901 (2021). https://doi.org/10.1007/s00125-021-05460-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-021-05460-0